Baxter International today announced the Sigma Spectrum Infusion System was named 2016 Best in KLAS for Smart Pumps – Large Volume Pumps (LVP) in the 2016 Best in KLAS: Medical Equipment report.
Baxter International (NYSE:BAX) today announced the Sigma Spectrum Infusion System was named 2016 Best in KLAS for Smart Pumps – Large Volume Pumps (LVP) in the 2016 Best in KLAS: Medical Equipment report. This is the fifth Best in KLAS award for Sigma Spectrum and is based on feedback from end users as well as opinions of hospital executives and managers who make purchasing decisions.
Receiving the Best in KLAS award signifies Sigma Spectrum
outperformed other smart pumps on the market and indicates a high level
of customer satisfaction with the platform and its support services. And
recently, Sigma Spectrum was recognized in the KLAS ”Smart
Pumps 2016: The Quest for Patient Safety” report as a leader in
drug library compliance and overall ease of use.
The Best in KLAS award reflects Baxter’s commitment to innovative
technology for medication delivery designed to enhance patient safety.
”Being named Best in KLAS once again is a particular honor
because it reflects how Sigma Spectrum pumps are being used to
support patient care,” said David Ferguson, Global Head of Baxter’s
Fluid Systems Franchise. ”Clinicians on the hospital floor need an
infusion pump that is easy-to-use, prioritizes patient safety and is
backed up by trusted training and support – all areas in which Sigma
KLAS Research specializes in monitoring and reporting the performance of
software, services and medical equipment vendors. To inform its latest
report, KLAS gathered performance feedback from Sigma Spectrum
users, who gave Sigma Spectrum high marks in a number of
categories that highlight Sigma Spectrum’s performance and safety
at the bedside.
The full ”2016 Best in KLAS: Medical Equipment” report is available
online at: http://www.data.klasresearch.com/PremiumReport/1133
About Sigma Spectrum Infusion System
Sigma Spectrum’s hardware works in concert with the pump’s
software to encourage use of innovative features that are designed to
help enhance patient safety and clinician efficiency. For example, the
pumps automatically default to the installed drug library without
requiring clinicians to take extra steps to ”opt-in,” and drug library
updates can be delivered wirelessly to pumps in the facility without
interrupting clinical workflow. Sigma Spectrum is the only pump
to include a built-in Dose/Rate Change Error Prevention Feature, which
helps clinicians protect high-risk infusions during titrations, and
allows pharmacists to customize dose change limits for individual drugs.
The Sigma Spectrum pump also includes built-in real-time location
tracking of equipment within a facility to protect against misplacement,
as well as enhanced data analytics and use of standard IV set technology
that can yield up to 53 percent cost savings in IV tubing sets and 30
percent reduction in IV tubing use.1
Rx Only. For the safe and proper use of this device, refer to the
appropriate operator’s manuals.
Baxter provides a broad portfolio of essential renal and hospital
products, including home, acute and in-center dialysis; sterile IV
solutions; infusion systems and devices; parenteral nutrition;
biosurgery products and anesthetics; and pharmacy automation, software
and services. The company’s global footprint and the critical nature of
its products and services play a key role in expanding access to
healthcare in emerging and developed countries. Baxter’s employees
worldwide are building upon the company’s rich heritage of medical
breakthroughs to advance the next generation of healthcare innovations
that enable patient care.
This release includes forward-looking statements concerning Baxter’s Sigma
Spectrum Infusion System and related performance data, including
anticipated benefits associated with its use. The statements are based
on assumptions about many important factors, including the following,
which could cause actual results to differ materially from those in the
forward-looking statements: satisfaction of regulatory and other
requirements; actions of regulatory bodies and other governmental
authorities; product quality, manufacturing or supply issues; patient
safety issues; changes in law and regulations; and other risks
identified in Baxter’s most recent filing on Form 10-K and other SEC
filings, all of which are available on Baxter’s website. Baxter does not
undertake to update its forward-looking statements.
Baxter and Sigma Spectrum are trademarks of Baxter
1 Data on File. Baxter Healthcare Corporation. Total cost of
ownership standard set technology inventory and cost reduction data
2011- 2013. *Data provided by these facilities. Baxter makes no
guarantee of cost savings.